Skip to main content

Table 1 Progression of the 12-month multi-modal exercise training program

From: Exercise as a diagnostic and therapeutic tool for preventing cardiovascular morbidity in breast cancer patients– the BReast cancer EXercise InTervention (BREXIT) trial protocol

Phase

Cycle

Weeks

Session Type

Frequency (per week)

Duration/Dose

Intensitya

Phase 1

Supervised Exercise During AC

1

1–3

Steady State & Resistance Training

2

SS: 30 mins

RT: 1–2 sets × 12–15 reps

SS: 10–20 b/min below %HRR at VT

RT: 60–70% 1RM

Interval Training

1

4 × 2 minsb

%HRR at VT ± 5 b/min

2

4–6

Steady State & Resistance Training

2

SS: 30 mins

RT: 2 sets × 12–15 reps

SS: 10–15 b/min below %HRR at VT

RT: 60–70% 1RM

Interval Training

1

4 × 3 minsb

%HRR at VT ± 5 b/min

3

7–9

Steady State & Resistance Training

2

SS: 30–35 min

RT: 2 sets × 18–12 reps

SS: 5–10 b/min below %HRR at VT

RT: 70–85% 1RM

Interval Training

1

4 × 3 minsb

85–95% HRpeak

4

10–12

Steady State & Resistance Training

2

SS: 35–40 min

RT: 2 sets × 8–12 reps

SS: 5–10 b/min below %HRR at VT

RT: 70–85% 1RM

Interval Training

1

4 × 4 minsb

85–95% HRpeak

Phase 2

Semi-supervised Exercise Following AC

1

13,15,17

Endurance Training

1

40–50 min

15–20 b/min below %HRR at VT

Tempo Training & Resistance Training

2

TT: 35 mins

RT: 2 sets × 8–12 reps

TT: 5–10 b/min below %HRR at VT

RT: 70–85% 1RM

Interval Training

1

4 × 4 minsb

85–95% HRpeak

14,16

Tempo Training

1

35 mins

5–10 b/min below %HRR at VT

Interval Training & Resistance Training

2

IT: 4 × 4 minsb

RT: 2 sets × 8–12 reps

IT: 85–95% HRpeak

RT: 70–85% 1RM

Recovery Session

1

30 mins

25–30 b/min below %HRR at VT

2

18,20,22

Tempo Training

1

35 mins

0–5 b/min below %HRR at VT

Interval Training & Resistance Training

2

IT: 4 × 4 minsb

RT: 2 sets × 8–12 reps

IT: 85–95% HRpeak

RT: 70–85% 1RM

Recovery Session

1

30 mins

20–25 b/min below %HRR at VT

19,21

Endurance Training

1

50–60 min

15–20 b/min below %HRR at VT

Tempo Training & Resistance Training

2

TT: 35 mins

RT: 2 sets × 8–12 reps

TT: %HRR at VT ± 5 b/min

RT: 2 sets × 8–12 reps

Interval Training

1

4 × 4 minsb

85–95% HRpeak

3

23,25

Endurance Training

1

60 mins

10–20 b/min below %HRR at VT

Tempo Training & Resistance Training

2

TT: 35 mins

RT: 2 sets × 8–12 reps

TT: %HRR at VT ± 10 b/min

RT: 70–85% 1RM

Interval Training

1

4 × 4 minsb

85–95% HRpeak

24,26

Tempo Training

1

35 mins

%HRR at VT ± 10 b/min

Interval Training & Resistance Training

2

IT: 4 × 4 minsb

RT: 2 sets × 8–12 reps

IT: 85–95% HRpeak

RT: 70–85% 1RM

Recovery Session

1

30 mins

20–25 b/min below %HRR at VT

Phase 3 Maintenance

n/a

27–52

Endurance Training

1

60 mins

10–20 b/min below %HRR at VT

Tempo Training & Resistance Training

2

TT: 35 mins

RT: 2 sets × 8–12 reps

TT: %HRR at VT ± 10 b/min

RT: 2 sets × 8–12 reps

Interval Training

1

4 × 4 minsb

85–95% HRpeak

  1. Abbreviations: %HRR Percentage of heart rate reserve, 1RM One repetition max, HRpeak Heart rate peak, IT Interval training, RT Resistance training, TT Tempo training, VT Ventilatory threshold
  2. aIntensity reduced by 5% from values reported in table during the week following chemotherapy administration
  3. bOnly duration for work phase of intervals is reported – duration for recovery phase was 3 min of light-intensity cycling